• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Ethics of Decentralized Clinical Trials and Informed Consent: Taking Technologies' Soft Impacts into Account.去中心化临床试验与知情同意的伦理:考虑技术的软性影响
Health Care Anal. 2025 Jun;33(2):139-150. doi: 10.1007/s10728-024-00483-1. Epub 2024 May 19.
2
Decentralized clinical trials (DCTs): A few ethical considerations.去中心化临床试验(DCTs):几点伦理考虑。
Front Public Health. 2022 Dec 15;10:1081150. doi: 10.3389/fpubh.2022.1081150. eCollection 2022.
3
Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics review.去中心化临床试验(DCT)的伦理审查:模拟伦理审查结果。
Drug Discov Today. 2022 Oct;27(10):103326. doi: 10.1016/j.drudis.2022.07.011. Epub 2022 Jul 20.
4
The Ethical Case for Decentralized Clinical Trials.去中心化临床试验的伦理案例。
Ethics Hum Res. 2024 Nov-Dec;46(6):14-24. doi: 10.1002/eahr.500229.
5
Diffused responsibilities in technology-driven health research: The case of artificial intelligence systems in decentralized clinical trials.技术驱动型健康研究中的责任分散:以去中心化临床试验中的人工智能系统为例。
Drug Discov Today. 2025 Feb;30(2):104309. doi: 10.1016/j.drudis.2025.104309. Epub 2025 Feb 3.
6
Ethical communication in clinical trials. Issues faced by data managers in obtaining informed consent.临床试验中的伦理沟通。数据管理者在获取知情同意书时面临的问题。
Cancer. 2002 Dec 1;95(11):2414-21. doi: 10.1002/cncr.10994.
7
Informed consent in paediatric critical care research--a South African perspective.儿科重症监护研究中的知情同意——南非视角
BMC Med Ethics. 2015 Sep 9;16:62. doi: 10.1186/s12910-015-0052-6.
8
Researcher and study participants' perspectives of consent in clinical studies in four referral hospitals in Vietnam.越南四家转诊医院内临床研究中同意书的研究人员和研究参与者观点。
BMC Med Ethics. 2020 Jan 10;21(1):4. doi: 10.1186/s12910-020-0445-z.
9
"A Question of Trust" and "a Leap of Faith"-Study Participants' Perspectives on Consent, Privacy, and Trust in Smart Home Research: Qualitative Study.《信任的问题》和《信仰的飞跃》——智能家居研究中参与者对同意、隐私和信任的看法:定性研究。
JMIR Mhealth Uhealth. 2021 Nov 26;9(11):e25227. doi: 10.2196/25227.
10
Researchers' perceptions of ethical challenges in cluster randomized trials: a qualitative analysis.研究者对整群随机试验中伦理挑战的看法:定性分析。
Trials. 2013 Jan 3;14:1. doi: 10.1186/1745-6215-14-1.

引用本文的文献

1
Exploring implementation challenges of decentralized clinical trials: A qualitative study of policy stakeholder perspectives in Denmark.探索去中心化临床试验的实施挑战:丹麦政策利益相关者观点的定性研究
Digit Health. 2025 Mar 28;11:20552076251330519. doi: 10.1177/20552076251330519. eCollection 2025 Jan-Dec.

本文引用的文献

1
Decentralised clinical trials: ethical opportunities and challenges.去中心化临床试验:伦理机遇与挑战。
Lancet Digit Health. 2023 Jun;5(6):e390-e394. doi: 10.1016/S2589-7500(23)00052-3. Epub 2023 Apr 25.
2
Ethics review of decentralized clinical trials (DCTs): Results of a mock ethics review.去中心化临床试验(DCT)的伦理审查:模拟伦理审查结果。
Drug Discov Today. 2022 Oct;27(10):103326. doi: 10.1016/j.drudis.2022.07.011. Epub 2022 Jul 20.
3
Assessment of the appropriateness of the i-CONSENT guidelines recommendations for improving understanding of the informed consent process in clinical studies.评估 i-CONSENT 指南建议在改善临床研究知情同意过程理解方面的适宜性。
BMC Med Ethics. 2021 Oct 13;22(1):138. doi: 10.1186/s12910-021-00708-1.
4
Clinical Research in Neonates: Redesigning the Informed Consent Process in the Digital Era.新生儿临床研究:数字时代知情同意流程的重新设计
Front Pediatr. 2021 Sep 1;9:724431. doi: 10.3389/fped.2021.724431. eCollection 2021.
5
Personalized and long-term electronic informed consent in clinical research: stakeholder views.临床研究中的个性化和长期电子知情同意:利益相关者的观点。
BMC Med Ethics. 2021 Jul 31;22(1):108. doi: 10.1186/s12910-021-00675-7.
6
Learning from remote decentralised clinical trial experiences: A qualitative analysis of interviews with trial personnel, patient representatives and other stakeholders.从远程去中心化临床试验经验中学习:对试验人员、患者代表和其他利益相关者进行访谈的定性分析。
Br J Clin Pharmacol. 2022 Mar;88(3):1031-1042. doi: 10.1111/bcp.15003. Epub 2021 Aug 12.
7
Navigating the ethics of remote research data collection.远程研究数据采集的伦理问题探讨
Clin Trials. 2021 Oct;18(5):606-614. doi: 10.1177/17407745211027245. Epub 2021 Jul 7.
8
Informed Consent, Understanding, and Trust.知情同意、理解与信任。
Am J Bioeth. 2021 May;21(5):61-63. doi: 10.1080/15265161.2021.1906987.
9
Ethical Considerations of Wearable Technologies in Human Research.可穿戴技术在人体研究中的伦理问题。
Adv Healthc Mater. 2021 Sep;10(17):e2100127. doi: 10.1002/adhm.202100127. Epub 2021 Apr 18.
10
Digital tools in the informed consent process: a systematic review.知情同意过程中的数字工具:一项系统综述
BMC Med Ethics. 2021 Feb 27;22(1):18. doi: 10.1186/s12910-021-00585-8.

去中心化临床试验与知情同意的伦理:考虑技术的软性影响

The Ethics of Decentralized Clinical Trials and Informed Consent: Taking Technologies' Soft Impacts into Account.

作者信息

van Rijssel Tessa I, van Thiel Ghislaine J M W, van Delden Johannes J M

机构信息

Department of Bioethics and Health Humanities, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.

出版信息

Health Care Anal. 2025 Jun;33(2):139-150. doi: 10.1007/s10728-024-00483-1. Epub 2024 May 19.

DOI:10.1007/s10728-024-00483-1
PMID:38764063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12052907/
Abstract

Decentralized clinical trials (DCTs) have the potential to advance the conduct of clinical trials, but raise several ethical issues, including obtaining valid informed consent. The debate on the ethical issues resulting from digitalization is predominantly focused on direct risks relating to for example data protection, safety, and data quality. We submit however, that a broader view on ethical aspects of DCTs is needed to touch upon the new challenges that come with the DCT practice. Digitalization has impacts that go beyond its direct purposes, by shaping behaviors, experiences, social relations, and values. We examine four elements of the informed consent procedure that are affected by DCTs, while taking these soft impacts of technologies into account: (i) informing participants and testing understanding, (ii) freedoms in relation to responsibilities and burdens, (iii) trust in participant-researcher relations, and (iv) impacts on the concept of privacy. Our analysis reveals that a broad view is key for optimal conduct of DCTs. In addition, it provides insight into the ethical impacts of DCTs on informed consent. Technologies such as DCTs potentially have profound impacts which are not immediately addressed by the existing regulatory frameworks, but nonetheless important to recognize. These findings can guide future practices of DCTs to foster the important values of clinical research in this novel approach for conducting clinical trials.

摘要

去中心化临床试验(DCTs)有推进临床试验开展的潜力,但也引发了若干伦理问题,包括获得有效的知情同意。关于数字化带来的伦理问题的辩论主要集中在例如数据保护、安全和数据质量等直接风险上。然而,我们认为,需要从更广泛的视角审视DCTs的伦理层面,以应对DCT实践带来的新挑战。数字化通过塑造行为、体验、社会关系和价值观,产生的影响超出了其直接目的。我们在考虑技术的这些软性影响的同时,研究了受DCTs影响的知情同意程序的四个要素:(i)告知参与者并测试其理解程度,(ii)与责任和负担相关的自由,(iii)对参与者与研究者关系的信任,以及(iv)对隐私概念的影响。我们的分析表明,广阔的视野是DCTs最佳开展的关键。此外,它还深入探讨了DCTs对知情同意的伦理影响。诸如DCTs之类的技术可能产生深远影响,现有监管框架并未立即涉及这些影响,但认识到这些影响仍然很重要。这些发现可以指导DCTs未来的实践,以在这种开展临床试验的新方法中促进临床研究的重要价值。